Drugs developed decades ago reduced Canadian mortality rates 49 percent – saving 847,000 life-years by 2022, and reduced hospital utilization by 55 percent – avoiding potential healthcare costs of $78.7 billion in 2022 alone

Lichtenberg study reveals virtuous legacy of pharmaceutical innovation: Canadian Health Policy Institute TORONTO, Aug. 11, 2025 /PRNewswire/ – New research from the world’s leading pharmaceutical economist affirms that Canadians continue to receive significant windfall gains from global…